Evo icl™ continues to outpace refractive industry growth. On that date, parents and families can view their child’s individual.
Staar surgical (nasdaq:staa) first quarter 2024 results key financial results. Thu, apr 4, 2024, 7:00 am 5 min.
Staar Surgical Announces Preliminary Net Sales For First Quarter 2024.
View the latest staa earnings date, analysts forecasts, earnings history, and conference call transcripts.
Staar Surgical Company (Nasdaq:k), A Leading Developer, Manufacturer And Marketer Of The Evo Family Of Implantable Collamer® Lenses (Evo Icl™) For Myopia,.
On that date, parents and families can view their child’s individual.
Images References :
Staar Surgical Reports Fourth Quarter And Fiscal Year 2023 Results.
Staar surgical (nasdaq:staa) first quarter 2024 results key financial results.
Staar Surgical Reports First Quarter 2024 Results.
View the latest staa earnings date, analysts forecasts, earnings history, and conference call transcripts.